What is the management approach for hemoperitoneum post Lower Segment Caesarean Section (LSCS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hemoperitoneum Post-LSCS

Hemoperitoneum following lower segment cesarean section requires immediate hemodynamic stabilization, urgent imaging with CT or ultrasound to identify the bleeding source, and surgical re-exploration in most cases, as conservative management is rarely successful for significant intra-abdominal hemorrhage. 1, 2

Immediate Stabilization and Assessment

  • Assess hemodynamic stability immediately by checking vital signs, signs of hypovolemia (tachycardia, hypotension, altered mental status), and severity of active bleeding 2
  • Establish large-bore IV access (two lines minimum) and initiate aggressive fluid resuscitation with crystalloids initially, followed by blood products as needed 2
  • Obtain baseline laboratory studies urgently: complete blood count, coagulation profile (PT, PTT, INR, fibrinogen), type and crossmatch for at least 4-6 units of packed red blood cells 2
  • Maintain normothermia (>36°C) as hypothermia severely impairs clotting factor function and worsens coagulopathy 2
  • Do not delay intervention while waiting for laboratory results if the patient is hemodynamically unstable—treat based on clinical presentation 2

Diagnostic Imaging

  • CT abdomen and pelvis with IV contrast is the gold standard for hemodynamically stable patients to determine the presence of active hemorrhage, localize bleeding, and identify the source 1
  • Look for specific CT findings: active contrast extravasation (indicates ongoing arterial bleeding), hematoma location (bladder flap, subfascial, perivaginal space), uterine rupture signs (gas in myometrial defect extending to parametrial tissue with hemoperitoneum), or uterine dehiscence (>5 cm bladder flap hematoma) 1
  • Transvaginal or transabdominal ultrasound can be performed at bedside for unstable patients to rapidly confirm hemoperitoneum, though it is less specific for identifying the bleeding source 3
  • Small hematomas (<4 cm) may not be clinically significant and can be managed conservatively, but larger collections require intervention 1

Surgical Management

Surgical re-exploration (relaparotomy or laparoscopy) is the definitive treatment for significant hemoperitoneum post-LSCS, as conservative management rarely controls substantial intra-abdominal bleeding 3

Indications for Immediate Surgical Intervention:

  • Hemodynamic instability despite aggressive resuscitation 2, 3
  • Active ongoing hemorrhage demonstrated on imaging 1
  • Large or expanding hematomas (>4-5 cm) 1
  • Signs of uterine rupture (gas in myometrial defect, parametrial extension) 1
  • Clinical deterioration with falling hemoglobin despite transfusion 3

Surgical Approach:

  • Relaparotomy is preferred for unstable patients or when extensive exploration is needed 3
  • Laparoscopy may be considered for stable patients with localized bleeding sources and adequate visualization 3
  • Perform systematic exploration: examine the uterine incision line, broad ligament vessels, ovarian vessels, bladder flap, and all peritoneal surfaces for bleeding sources 4, 3
  • Achieve meticulous hemostasis with suture ligation of bleeding vessels, as diffuse oozing may indicate coagulopathy requiring correction 3
  • Place surgical drains to monitor for rebleeding postoperatively 3

Massive Transfusion Protocol

  • Transfuse blood products in 1:1:1 ratio (packed red blood cells: fresh frozen plasma: platelets) if massive hemorrhage occurs (>1500 mL blood loss or ongoing bleeding) 2
  • Administer tranexamic acid (1 gram IV over 10 minutes, then 1 gram over 8 hours) within 3 hours of delivery to reduce bleeding risk 2
  • Correct coagulopathy aggressively: target fibrinogen >200 mg/dL with cryoprecipitate, platelets >50,000/mm³, INR <1.5 1, 2
  • Do not wait for laboratory confirmation before initiating massive transfusion protocol in clinically obvious hemorrhagic shock 2

Uterotonic Agents

  • Administer uterotonics aggressively even though the primary issue is surgical bleeding, as uterine atony may be a contributing factor 2
  • Oxytocin infusion: 10-40 units in 1000 mL crystalloid at 125-200 mL/hour 2
  • Methylergonovine 0.2 mg IM (avoid if hypertensive) 2
  • Carboprost 250 mcg IM every 15-90 minutes (maximum 8 doses; avoid if asthmatic) 2
  • Misoprostol 800-1000 mcg rectally 2

Interventional Radiology

  • Uterine artery embolization may be considered for hemodynamically stable patients with persistent bleeding after initial surgical control, particularly if a vascular source (pseudoaneurysm, arteriovenous malformation) is identified 1, 2
  • CTA (CT angiography) should be performed before embolization to identify feeding vessels and plan the procedure 1
  • Embolization is NOT appropriate for unstable patients or when uterine rupture/major surgical bleeding is suspected—these require immediate surgical repair 1

Specific Etiologies to Consider

Uterine Rupture:

  • CT findings: gas in myometrial defect extending to parametrial tissue, hemoperitoneum, disruption of all uterine layers including serosa 1
  • Requires immediate laparotomy with uterine repair or hysterectomy depending on extent of injury 1

Broad Ligament Vessel Rupture:

  • Rare but life-threatening cause of hemoperitoneum post-LSCS, often from variceal rupture or vessel injury during surgery 4
  • Requires surgical exploration with vessel ligation 4

Coagulopathy-Related:

  • Consider DIC, HELLP syndrome, or anaphylaxis if diffuse oozing without clear surgical source 1, 5
  • HELLP syndrome: check liver enzymes, LDH, peripheral smear for hemolysis 1
  • Anaphylaxis to prophylactic antibiotics: rare but can cause DIC and hemoperitoneum 5

Postoperative Management

  • Intensive care unit monitoring for at least 24-48 hours with continuous hemodynamic monitoring 2, 6
  • Serial hemoglobin/hematocrit checks every 4-6 hours initially to detect rebleeding 2
  • Monitor drain output closely for ongoing bleeding 3
  • Maintain low threshold for re-exploration if clinical deterioration, falling hemoglobin, or increasing drain output occurs 6
  • Initiate pharmacologic thromboprophylaxis with low molecular weight heparin once hemostasis is secured (typically 12-24 hours post-surgery) 2

Critical Pitfalls to Avoid

  • Never delay surgical intervention in hemodynamically unstable patients while pursuing imaging or conservative measures 2, 3
  • Do not underestimate blood loss: intra-abdominal bleeding can be massive (>3 liters) without obvious external signs 4, 3
  • Avoid blind digital examination before imaging excludes vascular abnormalities or placental complications 2, 7
  • Do not rely on initial hemoglobin as it may not reflect acute blood loss until hemodilution occurs hours later 3
  • Recognize that small hematomas on initial imaging can rapidly expand—maintain high clinical suspicion and repeat imaging if clinical deterioration occurs 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Retained Products of Conception with Vaginal Bleeding in Patients with Prior Cesarean Section

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The diagnosis and management of post-cesarean section hemorrhagic shock.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2008

Research

Hemoperitoneum in pregnancy from a ruptured varix of broad ligament.

Archives of gynecology and obstetrics, 2010

Guideline

Diagnosis and Management of Third Trimester Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation and Management of Postpartum Vaginal Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.